Otsuka Pharmaceutical Europe Ltd - Company Review
Otsuka Pharmaceutical Europe Ltd - Company ReviewSummary
Otsuka Pharmaceutical Europe Ltd (Otsuka Europe), a subsidiary of Otsuka Pharmaceutical Co Ltd is a healthcare organization that develops and markets pharmaceutical products. The organization offers products such as Samsca, Jinarc, Abilify, Pletal, Adacolumn, Sprycel and UbiT. Its products are used in the therapeutic areas of endocrinology, mental health, cardiovascular, gastroenterology and ophtholmology. Otsuka Europe performs preclinical research for new drugs to treat central nervous system, respiratory ailments, infectious diseases, and dermatological conditions, among others. It has sales and marketing operations in France, Germany, Italy, Spain, Switzerland, the UK and the Nordic region. Otsuka Europe is headquartered in Wexham, the UK.
This comprehensive company report of Otsuka Pharmaceutical Europe Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.